Skip to main content
. 2023 Jan 4;11(1):128. doi: 10.3390/biomedicines11010128
A2;3;4 astrocytoma grade 2;3;4
ADC apparent diffusion coefficient
BBB blood–brain barrier
BTV biological tumor volume
CNS central nervous system
CT computer tomography
DWI Diffusion-weighted imaging
E3 Ependymoma grade 3
EANO European Association of Neuro-oncology
ETMR Embryonal tumor with multilayer rosettes
FDG fluoro-deoxy-glucose
FDOPA 6-[18F]-L-fluoro-L-3, 4-dihydroxyphenylalanine
FET O-(2-[18F]fluoroethyl)-L-tyrosine
FLAIR fluid-attenuated inversion recovery
GBM glioblastoma
MET L-[11C]methyl-methionine
MRI magnetic resonance imaging
MRS magnetic resonance spectroscopy
NCCN National Comprehensive Cancer Network
O2;3 Oligodendroglioma grade 2;3
OSEM ordered subset expectation maximization
PBL Bayesian penalized likelihood
PET positron emission tomography
PWI perfusion-weighted imaging
rCBV relative cerebral blood volume
TBR tumor brain ratio
TOF time of flight